Digital Engagement in Healthcare: A Strategic Imperative for the Global South

How data-driven HCP engagement can strengthen health systems and accelerate innovation adoption in developing economies

Executive Summary

The digital transformation of healthcare is no longer confined to affluent nations. Across the Global South, connectivity gaps are narrowing, smartphones are proliferating, and health professionals are increasingly using online platforms to access medical research, drug information, and peer-reviewed guidelines. Yet many health systems still rely on traditional, one-size-fits-all approaches to engage clinicians—missing opportunities to improve care and institutional learning. In advanced markets, the rise of sophisticated digital engagement strategies—particularly in fast-moving therapeutic categories like GLP-1 obesity drugs—has demonstrated the power of behavioral data, predictive analytics, and lifecycle-aware communication. For the Global South, adopting a more strategic, data-informed approach to digital health engagement could accelerate the diffusion of clinical innovation, strengthen health workforce capacity, and contribute to long-term economic resilience. This article unpacks these strategies and translates them into a forward-looking agenda tailored to the realities of emerging economies.

Introduction

When a new class of medicines emerges—suddenly, culturally visible, and the subject of intense scientific discussion—how do healthcare professionals (HCPs) decide when and how to prescribe? The answer increasingly lies in their digital behavior. In advanced health systems, doctors now track trial results, label changes, and expert commentary on smartphones, medical portals, and even AI-powered search engines. Recent analyses of the GLP-1 receptor agonist market by IQVIA reveal a healthcare professional population that is highly attentive, deeply engaged with digital channels, and responsive to real-time developments: over 500,000 US HCPs wrote GLP-1 scripts in 2025 alone, and research activity spikes after clinical data releases and regulatory approvals. This experience holds critical lessons for the Global South, where non-communicable diseases (NCDs) such as diabetes and obesity are rising rapidly—and where digital infrastructure, though uneven, is expanding faster than traditional health system capacity.

Background: The Digital Shift in Healthcare Professional Engagement

Historically, pharmaceutical companies and health authorities reached clinicians primarily through in-person sales visits, medical conferences, and print journals. That model is now outdated in many parts of the world. Digitally native HCPs—whether in Boston, Bangalore, or Nairobi—seek information in real-time, compare treatment options through curated portals, and rely on targeted content that speaks directly to their patient populations. In the United States, the GLP-1 market has become a case study in this evolution. With obesity now a cultural and clinical priority, and with new oral formulations and multi-indication therapies entering the pipeline, HCPs face a rapidly expanding information landscape. Conventional, broad awareness campaigns no longer suffice; instead, successful engagement requires understanding the segmented, behavioral, and temporal nuances of how clinicians actually consume digital information.

Key patterns observed in the IQVIA analysis include a “long-tail” distribution of research activity, where a small proportion of high-engaging HCPs account for a disproportionate share of digital exploration, while the majority engages lightly. This heterogeneity, combined with shifting patient demand and competitive product differentiation, makes it essential to deploy advanced analytics—identifying which HCPs are researching a particular molecule, which are early adopters, and which may need targeted education on mechanisms of action or side-effect profiles.

The Main Analysis: Translating Digital Engagement Strategies to the Global South

1. Advanced Segmentation as a Development Tool

The same segmentation principles used to identify high-prescribing, high-research HCPs in the United States can be applied—with appropriate adaptation—to health systems in the Global South. In many low- and middle-income countries, the distribution of medical expertise is uneven: a small cadre of specialist physicians, particularly in urban referral centers, disproportionately influences prescribing habits in their regions. Advanced segmentation that incorporates digital behavior and clinical context can help health ministries and development partners tailor continuing medical education (CME) and training initiatives more effectively. For example, identifying which clinicians are actively searching for newborn care protocols versus diabetes management algorithms allows programs to deliver targeted content on mobile platforms, reducing time away from clinical duties and lowering system costs.

Moreover, in emerging markets, the economic health burden is shifting toward NCDs—many of which, like type 2 diabetes and obesity, are linked to urbanization and changing lifestyles. Digital segmentation can help governments identify which providers are likely to engage with new preventive care guidelines or generic version prescribing regimes, thus improving chronic care management at scale.

2. Real-Time Intelligence for Timely and Efficient Outreach

In the global fight against diseases, timing can be as critical as message content. When a new global recommendation is issued—for example, the World Health Organization’s updated guidelines on diabetes prevention—HCPs in developed markets immediately turn to digital channels. In the Global South, similar moments of regulatory approval or public-health emergency trigger an intense need for information. Yet, without robust digital intelligence and rapid response mechanisms, health authorities and partners often miss this peak interest window, resulting in slower adoption and persistent misinformation.

Investing in real-time digital listening tools—such as social media monitoring, search analytics, and targeted provider surveys—can allow national health systems to anticipate informational gaps and deploy evidence-based content within days, not months. This is especially relevant for newly approved medicines or vaccines, where clinicians need dose adjustments, contraindication alerts, and procurement details quickly. As mobile connectivity improves across sub-Saharan Africa and South Asia, such tools are increasingly viable.

3. Leveraging the Product Lifecycle to Strengthen Health Systems

While the concept of a product lifecycle is commercial, its underlying principle—that communication must evolve across stages of introduction, diffusion, and maturity—has clear public-health parallels. When a new health technology (a vaccine, a digital diagnostic, or an essential medicine) reaches a developing country, there are distinct phases: pre-introduction, early adoption, and widespread use. For example, the introduction of rotavirus vaccines in many African countries required pre-launch health worker sensitization, followed by monitoring of adverse events and catch-up campaigns. During the COVID-19 pandemic, the swift dissemination of changing clinical protocols benefited greatly from pre-planned, stage-based communication strategies.

The Global South can apply lifecycle thinking to its own digital engagement platforms. For a newly introduced hepatitis C therapy, for instance, a ministry of health could first engage specialist hepatologists through targeted digital content, then scale to general practitioners with simplified algorithms, and finally support community health workers with mobile decision-support tools. This staged approach optimizes use of scarce training resources and builds a sustainable base of knowledge within the health workforce.

4. From Awareness to Action: Measuring What Matters

In many development programs, success is still measured by output—how many health workers were trained, how many brochures were distributed, or how many times a website was accessed. As the GLP-1 experience demonstrates, the real metric of impact is behavioral change: prescription or adoption of a protocol. The IQVIA analysis notes that traditional, top-line awareness metrics lose salience in an environment where awareness is nearly universal—and where the need is to move HCPs to action.

For the Global South, this means shifting from counting “digital impressions” to tracking clinical uptake. Ministries of health and international organizations should invest in e-learning platforms with built-in assessment modules, and link them to electronic health records where feasible. Indicators such as the percentage of prescribers who adopt a new guideline, the average time to first use of a diagnostic instrument, or the rate of correct adherence to a treatment algorithm are far more meaningful. This shift will require upgrading health information systems and fostering a culture of data use at every level—from the facility to the central ministry.

Development Impact

The adoption of digital HCP engagement strategies can have direct development advantages. First, it improves health workforce capacity—one of the binding constraints in many Global South health systems—by making continuing education more accessible, personalized, and efficient. Second, it enhances resource stewardship: better-informed providers order fewer unnecessary tests and prescribe more appropriately, reducing health expenditures in countries where budgets are tight. Third, it drives broad-based technology adoption. When physicians become comfortable with digital clinical decision-support, they are more likely to embrace telehealth, AI-driven diagnostic aids, and e-prescription systems, creating a virtuous cycle of digital sophistication.

Additionally, a more digitally engaged health workforce can lower inequality in healthcare access. In rural-urban divides across Latin America, Asia, and Africa, digital engagement helps rural providers stay current without the cost and inconvenience of physical travel. This supports the goal of universal health coverage by ensuring that geography does not dictate the quality of care.

Global South Perspective

The Global South faces specific challenges—but also unique opportunities. Healthcare systems are often under-resourced, with an overburdened workforce and fragile data infrastructure. Yet the same technologies that enable digital engagement in the United States—cloud platforms, mobile-first communication tools, and AI-based learning systems—are becoming available at lower cost and with increasing interoperability. Many emerging markets can therefore “leapfrog” traditional models of CME and clinical communication by building digital-first strategies from the outset.

For regional bodies like the African Union, ASEAN, and ASEAN, and for South-South cooperation platforms, there is strong potential to pool digital engagement resources. Joint e-learning libraries, shared analytics on HCP behavior across borders, and regional virtual communities of practice could enable less wealthy countries to harness economies of scale. The African Academy of Sciences and the Asian Development Bank have already begun investing in digital health infrastructure, but a more coordinated approach could maximize returns.

Furthermore, indigenous pharmaceutical industries in emerging markets—India, Brazil, Indonesia—stand to benefit from a more digitally sophisticated HCP base. When generic manufacturers launch a new biosimilar or local innovation, they need not rely only on sales representatives; they can use digital channels to deliver clinical evidence and safety data quickly. This strengthens the local private sector and contributes to industrial development in life sciences as part of a broader national innovation agenda.

Future Outlook: 2025–2035

Over the next decade, digital health engagement will move from a “nice-to-have” to a core system component. Three trends are likely to shape the Global South. First, artificial intelligence (AI) will enable highly personalized content delivery—an AI engine could automatically identify that a clinician in Ghana has been researching hypertension and then push a relevant CME video or conference call. Second, the growing use of AI-powered search engines (like chat interfaces) among medical professionals means that health information systems must be structured to be “AI-discoverable,” using standardized metadata and open-access formats, to ensure that credible guidance surfaces when clinicians ask a question. Third, the expansion of mobile data coverage—including in least-developed countries—will make smartphone-based engagement the default channel for a majority of practitioners, even in remote areas.

The emergence of GLP-1 therapies and other advanced treatments also highlights a broader trend: the globalization of therapeutic innovation. In the future, drugs developed primarily for high-income markets will be increasingly available in the Global South, and HCPs there will need to learn how to use them—often amidst serious equity and affordability debates. Digital engagement can be used to promote rational prescribing, not just adoption, ensuring that new products do not crowd out basic health priorities. Policymakers and development finance institutions should invest in “engagement infrastructure” alongside clinical facilities, because a connected, informed health workforce is an asset that yields returns for years.

Conclusion

The message from advanced digital health markets is unmistakable: one-way, mass-message communication is no longer sufficient to change professional behavior. Data-driven, segmented, and lifecycle-aware digital engagement is now the standard of practice for pharmaceutical companies and health systems in the world’s wealthiest economies. For the Global South, embracing this modern approach is not an indulgence but a developmental necessity—one that can improve health outcomes, strengthen health systems, and position the region at the vanguard of global health innovation. By investing in enabling digital infrastructure, building data analytics capacity, and fostering South-South collaboration, the Global South can turn the digital world into a decisive advantage. The stakes are high, and the precedent is clear: those who engage clinicians where they already look for information will lead not only in commercial terms but in the broader quest for healthier, more sustainable societies.